Chemomab secures new patents for CM-101 monoclonal antibody

argenx receives FDA priority review for VYVGART Hytrulo in CIDP

Innovent Biologics' IBI311 achieves primary endpoint in phase three registrational study in Chinese subjects with Thyroid Eye Disease

Werfen receives CE mark for Aptiva Antiphospholipid Syndrome Immunoglobin G and Immunoglobulin M reagents

Diamyd Medical granted US FDA Fast Track designation for Diamyd diabetes treatment

Ono partners with Shattuck Labs for bifunctional fusion proteins

Artax Biopharma doses first subject in AX-158 Phase 2a psoriasis trial

Innovent Biologics announces CFO transition

Bio-Thera Solutions commences dosing in BAT6026 Phase IA/IIB clinical trial

Verici Dx partners with The Westmead Institute for Medical Research in Australian genomics health initiative

BioSenic expands patent coverage for ATO therapeutic platform

Celltrion USA submits CT-P47 Biologics License Application to FDA

NS Pharma's NS-229 receives European Commission orphan drug designation

Kyverna Therapeutics' KYV-101 granted US FDA fast track designation

InnoCare Pharma receives U.S. FDA clearance for ICP-248 clinical trial